The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Primary prophylaxis of febrile neutropenia using long-acting granulocyte colony-stimulating factors in female patients receiving dose-dense biweekly chemotherapy in the clinical routine.
 
Christian M. Kurbacher
Honoraria - Amgen; Fresenius Biotech; Novartis; Teva
Research Funding - Amgen (Inst); Fresenius Biotech (Inst); Hexal (Inst); Medac (Inst); Novartis (Inst); Roche Pharma AG (Inst); Teva (Inst)
 
A. Tabea Kurbacher
Honoraria - Amgen (I); Fresenius Biotech (I); Novartis (I); Teva (I)
Research Funding - Amgen (I); Fresenius Biotech (I); Hexal (I); Medac (I); Novartis (I); Roche Pharma AG (I); Teva (I)
 
Katja Monreal
No Relationships to Disclose
 
Claudia Schweitzer
No Relationships to Disclose
 
Sandra Sperling
No Relationships to Disclose
 
Gabriele Kolberg
No Relationships to Disclose
 
Jutta A. Kurbacher
Honoraria - Amgen (I); Fresenius Biotech (I); Novartis (I); Teva (I)
Research Funding - Amgen (I); Fresenius Biotech (I); Hexal (I); Medac (I); Novartis (I); Roche Pharma AG (I); Teva (I)